Global New Drug Research and Development Services Market

New Drug Research and Development Services Comprehensive Study by Drugs (Small-molecule drugs, Biologics drugs), Services (Chemistry Services, Biology Services), Therapeutic Areas (Oncology, Infectious and Immune system diseases, Neurology, Digestive system diseases, Cardiovascular diseases, Other), End User (Pharmaceutical & Biotechnology companies, Academic Institutes, Others (small CROs, IVD companies, and clinical laboratories)) Players and Region - Global Market Outlook to 2027

New Drug Research and Development Services Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global New Drug Research and Development Services Market Overview:
As the title actually suggests, drug advent lookup is lookup into producing new drugs, which can be damaged down into three stages: drug discovery research, drug improvement lookup and medical research. During drug discovery research, researchers appoint state-of the-art science to display screen for and perceive relatively wonderful compounds and additionally behavior fundamental lookup the use of exterior resources. The recognized drug candidates then proceed to the drug improvement stage, the place researchers lay the groundwork for submitting and approval round the world with the aid of evaluating the compounds' physicochemical and organic properties, assuring their high-quality and safety, and performing technique chemistry lookup into techniques of large-scale synthesis and manufacturing. Drug candidates that clear improvement lookup are then increased to the medical lookup stage. New product graph and improvement is frequently a quintessential component in the survival of a company. In a world industrial panorama that is altering fast, corporations should continuously revise their layout and vary of products. This is critical as nicely due to the fierce opposition and the evolving preferences of consumers. Without an R&D program, an association need to count number on strategic alliances, acquisitions, and networks to faucet into the improvements of others. In general, lookup and improvement things to do are carried out with the aid of specialised gadgets or facilities belonging to a company, or can be out-sourced to a contract lookup organization, universities, or kingdom agencies. In the context of commerce, "research and development" typically refers to future-oriented, longer-term activities in science or technology, the use of comparable strategies to scientific lookup however directed towards preferred results and with extensive forecasts of business yield.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Growth Drivers
  • Rising R & D Expenditure by the Pharmaceutical Companies
  • Increasing Demand for Outsourcing Analytical Testing
  • Initiatives for Research on Rare Diseases and Orphan Drugs

Roadblocks
  • Stringent Regulations Governing Drug Discovery and Animal Usage

Opportunities
  • Growth in Drugs and Biologics Market despite Covid-19 Pandemic
  • Rapidly Growing Biologics Industry

Challenges
  • Shortage of Skilled Personnel
  • Lack of Clinical Phenotyping and Patient Stratification
  • Increasingly Stiff Competition


Competitive Landscape:
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies.
Some of the key players profiled in the report are Syngene International Limited (India), Curia Global Inc. (United States), Dr. Reddy Laboratories Ltd. (Aurigene Discovery Technologies) (India), Pharmaron Beijing Co., Ltd. (China), Piramal Enterprises Limited (India), Thermo Fisher Scientific Inc. (United States), Jubilant Pharmova Limited (India), GenScript Biotech Corporation (United States), Selvita S.A. (Poland) and Shanghai Medicilon Inc. (China). Additionally, following companies can also be profiled that are part of our coverage like Viva Biotech (Shanghai) Ltd. (China), TCG Lifesciences Pvt Ltd. (India), Shanghai ChemPartner Co., Ltd. (China) and Domainex Ltd. (United Kingdom). Analyst at AMA Research see United States Players to retain maximum share of Global New Drug Research and Development Services market by 2027. Considering Market by Drugs, the sub-segment i.e. Small-molecule drugs will boost the New Drug Research and Development Services market. Considering Market by Services, the sub-segment i.e. Chemistry Services will boost the New Drug Research and Development Services market. Considering Market by Therapeutic Areas, the sub-segment i.e. Oncology will boost the New Drug Research and Development Services market. Considering Market by End User, the sub-segment i.e. Pharmaceutical & Biotechnology companies will boost the New Drug Research and Development Services market.

Latest Market Insights:
In September 2021, Eurofins collaborated with Liverpool ChiroChem Ltd to furnish more advantageous chemical know-how with the aid of getting access to LCC’s fragment library and PROTAC linker molecules to increase their built-in drug discovery platform, DiscoveryOne.

In December 2021, Curia (US) launched messenger RNA (mRNA) solution, which consists of discovery, procedure development, and mRNA drug substance production, via large-scale lipid manufacturing, lipid nanoparticle (LNP) formulation, and improvement for full-scale sterile fill-finish services.

What Can be Explored with the New Drug Research and Development Services Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global New Drug Research and Development Services Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in New Drug Research and Development Services
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global New Drug Research and Development Services market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in New Drug Research and Development Services market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Drugs
  • Small-molecule drugs
  • Biologics drugs

By Services
  • Chemistry Services
  • Biology Services

By Therapeutic Areas
  • Oncology
  • Infectious and Immune system diseases
  • Neurology
  • Digestive system diseases
  • Cardiovascular diseases
  • Other

By End User
  • Pharmaceutical & Biotechnology companies
  • Academic Institutes
  • Others (small CROs, IVD companies, and clinical laboratories)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising R & D Expenditure by the Pharmaceutical Companies
      • 3.2.2. Increasing Demand for Outsourcing Analytical Testing
      • 3.2.3. Initiatives for Research on Rare Diseases and Orphan Drugs
    • 3.3. Market Challenges
      • 3.3.1. Shortage of Skilled Personnel
      • 3.3.2. Lack of Clinical Phenotyping and Patient Stratification
      • 3.3.3. Increasingly Stiff Competition
    • 3.4. Market Trends
      • 3.4.1. Target-Based Screening Is the Preferred Approach to High-Throughput Screening
      • 3.4.2. Shift in Drug Discovery Services due to Growing Adoption of Ai-Based Tools
      • 3.4.3. Increased Outsourcing to Emerging Asian Economies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global New Drug Research and Development Services, by Drugs, Services, Therapeutic Areas, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global New Drug Research and Development Services (Value)
      • 5.2.1. Global New Drug Research and Development Services by: Drugs (Value)
        • 5.2.1.1. Small-molecule drugs
        • 5.2.1.2. Biologics drugs
      • 5.2.2. Global New Drug Research and Development Services by: Services (Value)
        • 5.2.2.1. Chemistry Services
        • 5.2.2.2. Biology Services
      • 5.2.3. Global New Drug Research and Development Services by: Therapeutic Areas (Value)
        • 5.2.3.1. Oncology
        • 5.2.3.2. Infectious and Immune system diseases
        • 5.2.3.3. Neurology
        • 5.2.3.4. Digestive system diseases
        • 5.2.3.5. Cardiovascular diseases
        • 5.2.3.6. Other
      • 5.2.4. Global New Drug Research and Development Services by: End User (Value)
        • 5.2.4.1. Pharmaceutical & Biotechnology companies
        • 5.2.4.2. Academic Institutes
        • 5.2.4.3. Others (small CROs, IVD companies, and clinical laboratories)
      • 5.2.5. Global New Drug Research and Development Services Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. New Drug Research and Development Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Syngene International Limited (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Curia Global Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Dr. Reddy Laboratories Ltd. (Aurigene Discovery Technologies) (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pharmaron Beijing Co., Ltd. (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Piramal Enterprises Limited (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Thermo Fisher Scientific Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Jubilant Pharmova Limited (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GenScript Biotech Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Selvita S.A. (Poland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Shanghai Medicilon Inc. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global New Drug Research and Development Services Sale, by Drugs, Services, Therapeutic Areas, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global New Drug Research and Development Services (Value)
      • 7.2.1. Global New Drug Research and Development Services by: Drugs (Value)
        • 7.2.1.1. Small-molecule drugs
        • 7.2.1.2. Biologics drugs
      • 7.2.2. Global New Drug Research and Development Services by: Services (Value)
        • 7.2.2.1. Chemistry Services
        • 7.2.2.2. Biology Services
      • 7.2.3. Global New Drug Research and Development Services by: Therapeutic Areas (Value)
        • 7.2.3.1. Oncology
        • 7.2.3.2. Infectious and Immune system diseases
        • 7.2.3.3. Neurology
        • 7.2.3.4. Digestive system diseases
        • 7.2.3.5. Cardiovascular diseases
        • 7.2.3.6. Other
      • 7.2.4. Global New Drug Research and Development Services by: End User (Value)
        • 7.2.4.1. Pharmaceutical & Biotechnology companies
        • 7.2.4.2. Academic Institutes
        • 7.2.4.3. Others (small CROs, IVD companies, and clinical laboratories)
      • 7.2.5. Global New Drug Research and Development Services Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. New Drug Research and Development Services: by Drugs(USD Million)
  • Table 2. New Drug Research and Development Services Small-molecule drugs , by Region USD Million (2016-2021)
  • Table 3. New Drug Research and Development Services Biologics drugs , by Region USD Million (2016-2021)
  • Table 4. New Drug Research and Development Services: by Services(USD Million)
  • Table 5. New Drug Research and Development Services Chemistry Services , by Region USD Million (2016-2021)
  • Table 6. New Drug Research and Development Services Biology Services , by Region USD Million (2016-2021)
  • Table 7. New Drug Research and Development Services: by Therapeutic Areas(USD Million)
  • Table 8. New Drug Research and Development Services Oncology , by Region USD Million (2016-2021)
  • Table 9. New Drug Research and Development Services Infectious and Immune system diseases , by Region USD Million (2016-2021)
  • Table 10. New Drug Research and Development Services Neurology , by Region USD Million (2016-2021)
  • Table 11. New Drug Research and Development Services Digestive system diseases , by Region USD Million (2016-2021)
  • Table 12. New Drug Research and Development Services Cardiovascular diseases , by Region USD Million (2016-2021)
  • Table 13. New Drug Research and Development Services Other , by Region USD Million (2016-2021)
  • Table 14. New Drug Research and Development Services: by End User(USD Million)
  • Table 15. New Drug Research and Development Services Pharmaceutical & Biotechnology companies , by Region USD Million (2016-2021)
  • Table 16. New Drug Research and Development Services Academic Institutes , by Region USD Million (2016-2021)
  • Table 17. New Drug Research and Development Services Others (small CROs, IVD companies, and clinical laboratories) , by Region USD Million (2016-2021)
  • Table 18. South America New Drug Research and Development Services, by Country USD Million (2016-2021)
  • Table 19. South America New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 20. South America New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 21. South America New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 22. South America New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 23. Brazil New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 24. Brazil New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 25. Brazil New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 26. Brazil New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 27. Argentina New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 28. Argentina New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 29. Argentina New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 30. Argentina New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 31. Rest of South America New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 32. Rest of South America New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 33. Rest of South America New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 34. Rest of South America New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 35. Asia Pacific New Drug Research and Development Services, by Country USD Million (2016-2021)
  • Table 36. Asia Pacific New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 37. Asia Pacific New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 38. Asia Pacific New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 39. Asia Pacific New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 40. China New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 41. China New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 42. China New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 43. China New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 44. Japan New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 45. Japan New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 46. Japan New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 47. Japan New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 48. India New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 49. India New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 50. India New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 51. India New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 52. South Korea New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 53. South Korea New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 54. South Korea New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 55. South Korea New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 56. Taiwan New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 57. Taiwan New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 58. Taiwan New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 59. Taiwan New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 60. Australia New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 61. Australia New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 62. Australia New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 63. Australia New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 68. Europe New Drug Research and Development Services, by Country USD Million (2016-2021)
  • Table 69. Europe New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 70. Europe New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 71. Europe New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 72. Europe New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 73. Germany New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 74. Germany New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 75. Germany New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 76. Germany New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 77. France New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 78. France New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 79. France New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 80. France New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 81. Italy New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 82. Italy New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 83. Italy New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 84. Italy New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 85. United Kingdom New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 86. United Kingdom New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 87. United Kingdom New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 88. United Kingdom New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 89. Netherlands New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 90. Netherlands New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 91. Netherlands New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 92. Netherlands New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 93. Rest of Europe New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 94. Rest of Europe New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 95. Rest of Europe New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 96. Rest of Europe New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 97. MEA New Drug Research and Development Services, by Country USD Million (2016-2021)
  • Table 98. MEA New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 99. MEA New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 100. MEA New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 101. MEA New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 102. Middle East New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 103. Middle East New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 104. Middle East New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 105. Middle East New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 106. Africa New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 107. Africa New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 108. Africa New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 109. Africa New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 110. North America New Drug Research and Development Services, by Country USD Million (2016-2021)
  • Table 111. North America New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 112. North America New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 113. North America New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 114. North America New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 115. United States New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 116. United States New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 117. United States New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 118. United States New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 119. Canada New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 120. Canada New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 121. Canada New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 122. Canada New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 123. Mexico New Drug Research and Development Services, by Drugs USD Million (2016-2021)
  • Table 124. Mexico New Drug Research and Development Services, by Services USD Million (2016-2021)
  • Table 125. Mexico New Drug Research and Development Services, by Therapeutic Areas USD Million (2016-2021)
  • Table 126. Mexico New Drug Research and Development Services, by End User USD Million (2016-2021)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. New Drug Research and Development Services: by Drugs(USD Million)
  • Table 138. New Drug Research and Development Services Small-molecule drugs , by Region USD Million (2022-2027)
  • Table 139. New Drug Research and Development Services Biologics drugs , by Region USD Million (2022-2027)
  • Table 140. New Drug Research and Development Services: by Services(USD Million)
  • Table 141. New Drug Research and Development Services Chemistry Services , by Region USD Million (2022-2027)
  • Table 142. New Drug Research and Development Services Biology Services , by Region USD Million (2022-2027)
  • Table 143. New Drug Research and Development Services: by Therapeutic Areas(USD Million)
  • Table 144. New Drug Research and Development Services Oncology , by Region USD Million (2022-2027)
  • Table 145. New Drug Research and Development Services Infectious and Immune system diseases , by Region USD Million (2022-2027)
  • Table 146. New Drug Research and Development Services Neurology , by Region USD Million (2022-2027)
  • Table 147. New Drug Research and Development Services Digestive system diseases , by Region USD Million (2022-2027)
  • Table 148. New Drug Research and Development Services Cardiovascular diseases , by Region USD Million (2022-2027)
  • Table 149. New Drug Research and Development Services Other , by Region USD Million (2022-2027)
  • Table 150. New Drug Research and Development Services: by End User(USD Million)
  • Table 151. New Drug Research and Development Services Pharmaceutical & Biotechnology companies , by Region USD Million (2022-2027)
  • Table 152. New Drug Research and Development Services Academic Institutes , by Region USD Million (2022-2027)
  • Table 153. New Drug Research and Development Services Others (small CROs, IVD companies, and clinical laboratories) , by Region USD Million (2022-2027)
  • Table 154. South America New Drug Research and Development Services, by Country USD Million (2022-2027)
  • Table 155. South America New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 156. South America New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 157. South America New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 158. South America New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 159. Brazil New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 160. Brazil New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 161. Brazil New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 162. Brazil New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 163. Argentina New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 164. Argentina New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 165. Argentina New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 166. Argentina New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 167. Rest of South America New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 168. Rest of South America New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 169. Rest of South America New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 170. Rest of South America New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 171. Asia Pacific New Drug Research and Development Services, by Country USD Million (2022-2027)
  • Table 172. Asia Pacific New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 173. Asia Pacific New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 174. Asia Pacific New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 175. Asia Pacific New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 176. China New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 177. China New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 178. China New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 179. China New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 180. Japan New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 181. Japan New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 182. Japan New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 183. Japan New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 184. India New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 185. India New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 186. India New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 187. India New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 188. South Korea New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 189. South Korea New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 190. South Korea New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 191. South Korea New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 192. Taiwan New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 193. Taiwan New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 194. Taiwan New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 195. Taiwan New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 196. Australia New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 197. Australia New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 198. Australia New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 199. Australia New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 200. Rest of Asia-Pacific New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 201. Rest of Asia-Pacific New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 202. Rest of Asia-Pacific New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 203. Rest of Asia-Pacific New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 204. Europe New Drug Research and Development Services, by Country USD Million (2022-2027)
  • Table 205. Europe New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 206. Europe New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 207. Europe New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 208. Europe New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 209. Germany New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 210. Germany New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 211. Germany New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 212. Germany New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 213. France New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 214. France New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 215. France New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 216. France New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 217. Italy New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 218. Italy New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 219. Italy New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 220. Italy New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 221. United Kingdom New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 222. United Kingdom New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 223. United Kingdom New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 224. United Kingdom New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 225. Netherlands New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 226. Netherlands New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 227. Netherlands New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 228. Netherlands New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 229. Rest of Europe New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 230. Rest of Europe New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 231. Rest of Europe New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 232. Rest of Europe New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 233. MEA New Drug Research and Development Services, by Country USD Million (2022-2027)
  • Table 234. MEA New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 235. MEA New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 236. MEA New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 237. MEA New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 238. Middle East New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 239. Middle East New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 240. Middle East New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 241. Middle East New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 242. Africa New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 243. Africa New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 244. Africa New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 245. Africa New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 246. North America New Drug Research and Development Services, by Country USD Million (2022-2027)
  • Table 247. North America New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 248. North America New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 249. North America New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 250. North America New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 251. United States New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 252. United States New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 253. United States New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 254. United States New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 255. Canada New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 256. Canada New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 257. Canada New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 258. Canada New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 259. Mexico New Drug Research and Development Services, by Drugs USD Million (2022-2027)
  • Table 260. Mexico New Drug Research and Development Services, by Services USD Million (2022-2027)
  • Table 261. Mexico New Drug Research and Development Services, by Therapeutic Areas USD Million (2022-2027)
  • Table 262. Mexico New Drug Research and Development Services, by End User USD Million (2022-2027)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global New Drug Research and Development Services: by Drugs USD Million (2016-2021)
  • Figure 5. Global New Drug Research and Development Services: by Services USD Million (2016-2021)
  • Figure 6. Global New Drug Research and Development Services: by Therapeutic Areas USD Million (2016-2021)
  • Figure 7. Global New Drug Research and Development Services: by End User USD Million (2016-2021)
  • Figure 8. South America New Drug Research and Development Services Share (%), by Country
  • Figure 9. Asia Pacific New Drug Research and Development Services Share (%), by Country
  • Figure 10. Europe New Drug Research and Development Services Share (%), by Country
  • Figure 11. MEA New Drug Research and Development Services Share (%), by Country
  • Figure 12. North America New Drug Research and Development Services Share (%), by Country
  • Figure 13. Global New Drug Research and Development Services share by Players 2021 (%)
  • Figure 14. Global New Drug Research and Development Services share by Players (Top 3) 2021(%)
  • Figure 15. Global New Drug Research and Development Services share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Syngene International Limited (India) Revenue, Net Income and Gross profit
  • Figure 18. Syngene International Limited (India) Revenue: by Geography 2021
  • Figure 19. Curia Global Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Curia Global Inc. (United States) Revenue: by Geography 2021
  • Figure 21. Dr. Reddy Laboratories Ltd. (Aurigene Discovery Technologies) (India) Revenue, Net Income and Gross profit
  • Figure 22. Dr. Reddy Laboratories Ltd. (Aurigene Discovery Technologies) (India) Revenue: by Geography 2021
  • Figure 23. Pharmaron Beijing Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 24. Pharmaron Beijing Co., Ltd. (China) Revenue: by Geography 2021
  • Figure 25. Piramal Enterprises Limited (India) Revenue, Net Income and Gross profit
  • Figure 26. Piramal Enterprises Limited (India) Revenue: by Geography 2021
  • Figure 27. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 29. Jubilant Pharmova Limited (India) Revenue, Net Income and Gross profit
  • Figure 30. Jubilant Pharmova Limited (India) Revenue: by Geography 2021
  • Figure 31. GenScript Biotech Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. GenScript Biotech Corporation (United States) Revenue: by Geography 2021
  • Figure 33. Selvita S.A. (Poland) Revenue, Net Income and Gross profit
  • Figure 34. Selvita S.A. (Poland) Revenue: by Geography 2021
  • Figure 35. Shanghai Medicilon Inc. (China) Revenue, Net Income and Gross profit
  • Figure 36. Shanghai Medicilon Inc. (China) Revenue: by Geography 2021
  • Figure 37. Global New Drug Research and Development Services: by Drugs USD Million (2022-2027)
  • Figure 38. Global New Drug Research and Development Services: by Services USD Million (2022-2027)
  • Figure 39. Global New Drug Research and Development Services: by Therapeutic Areas USD Million (2022-2027)
  • Figure 40. Global New Drug Research and Development Services: by End User USD Million (2022-2027)
  • Figure 41. South America New Drug Research and Development Services Share (%), by Country
  • Figure 42. Asia Pacific New Drug Research and Development Services Share (%), by Country
  • Figure 43. Europe New Drug Research and Development Services Share (%), by Country
  • Figure 44. MEA New Drug Research and Development Services Share (%), by Country
  • Figure 45. North America New Drug Research and Development Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Syngene International Limited (India)
  • Curia Global Inc. (United States)
  • Dr. Reddy Laboratories Ltd. (Aurigene Discovery Technologies) (India)
  • Pharmaron Beijing Co., Ltd. (China)
  • Piramal Enterprises Limited (India)
  • Thermo Fisher Scientific Inc. (United States)
  • Jubilant Pharmova Limited (India)
  • GenScript Biotech Corporation (United States)
  • Selvita S.A. (Poland)
  • Shanghai Medicilon Inc. (China)
Additional players considered in the study are as follows:
Viva Biotech (Shanghai) Ltd. (China) , TCG Lifesciences Pvt Ltd. (India) , Shanghai ChemPartner Co., Ltd. (China) , Domainex Ltd. (United Kingdom)
Select User Access Type

Key Highlights of Report


Jul 2022 200 Pages 61 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global New Drug Research and Development Services Market Quantitative research analysis
Global New Drug Research and Development Services Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global New Drug Research and Development Services market are Syngene International Limited (India), Curia Global Inc. (United States), Dr. Reddy Laboratories Ltd. (Aurigene Discovery Technologies) (India), Pharmaron Beijing Co., Ltd. (China), Piramal Enterprises Limited (India), Thermo Fisher Scientific Inc. (United States), Jubilant Pharmova Limited (India), GenScript Biotech Corporation (United States), Selvita S.A. (Poland) and Shanghai Medicilon Inc. (China), to name a few.
"Target-Based Screening Is the Preferred Approach to High-Throughput Screening " is seen as one of major influencing trends for New Drug Research and Development Services Market during projected period 2021-2027.
dominated the New Drug Research and Development Services market. This is attributable to growing trend of "Target-Based Screening Is the Preferred Approach to High-Throughput Screening "

Know More About Global New Drug Research and Development Services Market Report?

Have a Query? Click Here

Other Related Reports

Smart Agriculture Precision Farming - Comprehensive Study by Type (Tractor, Thresor, IOT, Duster, Other), Robotics Tools (Processing Unit, Crop Cutter, GPS Tool, Sensor Tool), End User (Farmer, Agri...
$ 3500
Sleep Technology Comprehensive Study by Type (Wearables and Fitness Trackers, Smart Bed and Mattresses, Externals Monitoring, Sound Technology), Application (Healthcare, Hospitals), End User (Residen...
$ 3800